Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 84,059

Document Document Title
WO/2014/112666A1
The present invention relates to a method for preparing an extract from the mycelial culture medium of Ceriporia lacerata and a pharmaceutical composition for preventing or treating diabetic diseases and diabetic complications prepared b...  
WO/2014/113208A1
This invention provides compositions for the production of butanol. Specifically, the compositions of the present invention use syntrophic co-cultures for the production of butanol from syngas.  
WO/2014/112627A1
The present invention addresses the problem of providing a series of techniques for producing 1,4-butanediol from methanol or the like. A recombinant cell which is produced by introducing a gene encoding at least one enzyme selected from...  
WO/2014/113541A1
The invention provides vectors, attenuated pathogens, compositions, methods, and kits for use in preventing or treating infection by an infectious pathogen, especially Chlamydia trachomatis. The vectors comprise the plasmid encoded ppg g...  
WO/2014/112637A1
The purpose of the present invention is to make it possible to easily concentrate a metal of a metal-ion-containing solution at a high efficiency and recover the metal from the metal-ion-containing solution at a high recovery efficiency....  
WO/2014/110097A3
Methods and systems for identifying inhibitors of Equilibrative Nucleoside Transporters are provided. Methods and systems for identifying inhibitors of Concentrative Nucleoside Transporters are also provided.  
WO/2014/107953A1
Provided is a C-terminal domain of xylanase XynA originally from a rumen and a method for improving xylanase catalytic efficiency. A new xylanase with high efficiency is provided. The optimum pH of the xylanase in the present invention i...  
WO/2014/108856A1
The present disclosure relates to a comprehensive model for expression of recombinant peptides by Pichia pastoris. The model uses an easily controllable variable called 'critical nutrient ratio' for obtaining a right balance between prod...  
WO/2014/109360A1
Provided is a method which comprises developing a high-expression promoter of Pseudozyma antarctica, constructing a heterologous protein production system with the use of the obtained high-expression promoter, and then efficiently produc...  
WO/2014/108937A1
The present invention provides a novel lactobacillus strain having excellent lactic-acid generating properties and extremely excellent high temperature resistance. This lactobacillus has a high temperature resistance such that the lactob...  
WO/2014/107815A3
A method for high-efficiency genetic transformation of the anaerobic bacterium Clostridium pasteurianum is provided. Clostridium pasteurianum is industrially important due to its selective and high level production of the biofuel and bio...  
WO/2014/109438A1
The present invention relates to a new microalgae Chlorella sp. for accumulating a functional starch and lipid at high concentrations. The cell strain Chlorella sp. ArM29B according to the present invention has been confirmed to be a cel...  
WO/2014/107815A2
By this invention, for the first time, a method for high-efficiency genetic transformation of the anaerobic bacterium Clostridium pasteurianum is provided. Clostridium pasteurianum is a bacterium of substantial industrial importance, due...  
WO/2014/110205A1
The technology described herein relates to siRNAs, e.g., methods and compositions relating to the production of siRNAs in bacterial cells.  
WO/2014/107863A1
Provided are a plant protein and the coding gene and use thereof, in particular provided are a homeotic-leucine zipper protein GhHDbZIP-1 from cotton and the coding gene thereof, and use thereof for cultivating transgenic plants having i...  
WO/2014/107660A2
Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical nitrogen sources, such as melamine and cyanamide. Fermentation methods using the genetically engineered organisms ar...  
WO/2014/106886A1
Peptide vaccines against cancer are described herein. In particular, isolated epitope peptides derived from the CDCA5 that elicit CTLs and thus are suitable for use in the context of cancer immunotherapy are provided. Further provided ar...  
WO/2014/107660A3
Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical nitrogen sources, such as melamine and cyanamide. Fermentation methods using the genetically engineered organisms ar...  
WO/2014/107107A2
1. A Streptomyces sp. N02 strain, characterized by a 16S rDNA sequence SEQ No. 1. 2. A method for selecting a strain as claimed in claim 1, characterized in that it comprises the following steps - bringing a sample of the rhizosphere of ...  
WO/2014/106583A1
The present invention relates to a polypeptide binding to human serum albumin and comprising or consisting of an amino acid sequence selected from the group consisting of: (a) GVTLFVALYDY(X1)(X2)(X3)(X4)(X5)(X6)D(X7)SFHKGEKFQIL(X8)(X9)( ...  
WO/2014/107106A1
This invention relates to the use of the Amycolatopsis sp. RC21 strain, of a mutant strain or of an active compound for inhibiting the growth of the causal agent of tuberculosis, and/or inhibiting the proliferation of cancer cells and/or...  
WO/2014/107107A3
1. A Streptomyces sp. N02 strain, characterized by a 16S rDNA sequence SEQ No. 1. 2. A method for selecting a strain as claimed in claim 1, characterized in that it comprises the following steps - bringing a sample of the rhizosphere of ...  
WO/2014/102241A1
The invention relates to a process for identifying gene(s)/genetic element(s) associated with mating impairment in strains of Trichoderma reesei QM6a or strains derived thereof comprising the steps of a) providing a first strain being a ...  
WO/2014/103957A1
The invention provides: an AAV particle containing an adeno-associated viral (AAV) capsid protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 24, and SEQ ID NO: 30 of the s...  
WO/2014/104318A1
[Problem] To provide a bacterial cellulose which is highly dispersible in a liquid, shows excellent molding properties and high miscibility with other materials when applied to materials, and, therefore, has a high applicability as a pra...  
WO/2014/104094A1
Provided are avian myeoblastosis virus (AMV) reverse transcriptase with improved heat stability and a method for producing the same. The AMV reverse transcriptase with improved heat stability can be obtained by substituting an amino acid...  
WO/2014/105671A1
The present invention relates to an immunogenic composition comprising: a) one or more antigen of M. hyorhinis and one or more antigens of M. hyosynoviae; and b) a pharmaceutically acceptable carrier. Furthermore, the present invention r...  
WO/2014/101121A1
Disclosed are a zinc finger protein (Czf7)coming from cotton, the encoding gene thereof and use thereof in cultivating of a transgenic plant with improved drought resistance.  
WO/2014/103608A1
A chimeric protein made from a HPV-L2 peptide and an HBs protein, said HPV-L2 peptide being one of the following: (1) a peptide comprising the 20 amino acids of the core sequence region; (2) a peptide comprising part of the core sequence...  
WO/2014/104883A1
The invention is related to a new bacterium comprising a partial 16S rDNA nucleic acid sequence having more than 85% sequence identity to the sequence presented as SEQ ID NO:1, or the complement thereof and a consortium of micro-organism...  
WO/2014/104755A1
The present invention relates to a method for preparing, from wood-based biomass, a high concentration of fermentable sugar which can be effectively used in culturing various industrial fermented bacteria. According to the method of the ...  
WO/2014/102254A1
Process for the production of lipids from biomass including at least one polysaccharide, which comprises fermentation of a biomass hydrolysate using an oleaginous microorganism and separation of oleaginous cellular biomass comprising lip...  
WO/2014/104202A1
The present invention addresses the problem of providing a series of techniques for producing isoprene from methanol, etc. Provided is a recombinant cell wherein a gene encoding isoprene synthase is transferred into a host cell that is a...  
WO/2014/102757A1
The present application describes a method for obtaining peptide and polysaccharide extracts from Brewer's yeast autolysate by enzymatic hydrolysis and filtration techniques. Also described are the peptide and polysaccharide extracts obt...  
WO/2014/104998A1
The present invention relates to producing micropropagules from Trichoderma citrinoviride EGE-K-130 mould strain isolated from resources of our country and whose strain is molecularly identified, as a bio-control agent by means of an eco...  
WO/2014/106026A1
Animal feed conversion ratio can be increased and blood glucose levels can be decreased by feeding an efficacious amount of dispersible amorphous poly(3-hydroxybutyrate/3- hydroxy valerate).  
WO/2014/101857A1
Provided is a fermentation production method of docosahexenoic acid (DHA), in particular a liquid fermentation production method of DHA through solid material cultivation of the Schizochytrium. The method comprises steps of activation of...  
WO/2014/102703A1
The invention relates to a bacterial strain belonging to the genus Rhodococcus which is a producer of a nitrile hydratase. The invention also relates to a method for producing acrylamide by hydration of acrylonitrile using a biomass of t...  
WO/2014/103930A1
An enzyme acyl-ACP thioesterase comprising an amino acid sequence lying between position-115 to position-274 in SEQ ID NO: 1; an acyl-ACP thioesterase gene encoding the protein; a transformant carrying the gene; and a method for producin...  
WO/2014/105672A1
The present invention relates to a method for the preparation of an immunogenic composition for the treatment and/or prophylaxis of mycoplasma infections in a subject comprising the cultivation of mycoplasma bacteria in a serum-reduced o...  
WO/2014/104076A1
Provided is a euglena in which an objective exogeneous gene is held in an expressible state. The euglena has a chemical-resistant gene and an objective exogeneous gene which are held therein in an expressible state.  
WO/2014/101367A1
Disclosed in the present invention are a nucleotide sequence shown in SEQ ID No.1, and a recombinant vector and recombinant bacteria which contain the nucleotide sequence; and further disclosed in the present invention are a method for e...  
WO/2014/100920A1
Provided is an engineering bacteria for producing DL-alanine. Lactic dehydrogenase, pyruvate formate lyase, ethanol dehydrogenase, acetic acid kinase, fumaric acid reductase, alanine racemase and methyl glyoxal synthetase of the engineer...  
WO/2014/102551A1
An enclosed bioremediation system utilizing resistant micro-evolved microbes for treatment of wastewater and recovery of chemicals and metals and which also results in biomass and biochemical production and carbon capture.  
WO/2014/104310A1
Provided is a method for readily and inexpensively producing cellulose. The production method uses a cellulose production vector having a promoter, a CesA gene, and a CesB gene, and having an upstream sequence of a 5'-side gene in a 5'-s...  
WO/2014/100461A2
Provided are engineered microorganisms capable of producing fatty dicarboxylic acids and products expressed by such microorganisms. Also provided are biological methods for producing fatty dicarboxylic acids.  
WO/2014/094279A1
Provided is the use of Bifidobacterium animalis subsp. lactis strain CNCM I-2494 for decreasing diet-induced body weight gain and improving diet-induced insulin resistance in a subject.  
WO/2014/099509A1
Though chlorine dioxide is generally used to control bacterial contamination, a method was developed which allows the use of stabilized chlorine dioxide (SCD) for controlling contamination during fermentation that uses the bacteria Zymom...  
WO/2014/098112A1
[Problem] The purpose of the present invention is to stably supply high-quality and highly uniform Wisteria floribunda agglutinin (WFA) that recognizes biologically important sugar-chain markers, to elucidate the sugar-chain recognition ...  
WO/2014/097321A1
The invention relates to a process of production of novel cutinases from Thermobifida fusca NRRL B-8184 strain in E. coli BL21 (DE3) using pET22b (+) expression vector. It specifically relates to recombinant construction, expression and ...  

Matches 301 - 350 out of 84,059